Publications en rapport avec les thèmes de recherche du CiMoT heMA

Barrier L, Fauconneau B, Noël A, Ingrand S. Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APP and APP/PS1 Mouse Models of Alzheimer’s Disease : Relationship with the Lack of Neurodegeneration ? Int J Alzheimers Dis. 2010; 920958.

Barrier L, Ingrand S, Fauconneau BPage G. Gender dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease. Neurobiol Aging. 2010; 31(11):1843-53.

Chavant F, Deguil J, Pain S, Ingrand I, Milin SFauconneau B, Perault MC, Lafay-Chebassier C. Imipramine, in part through TNF-alpha inhibition, prevents cognitive decline and Abeta accumulation in a mouse model of Alzheimer’s disease. J Pharmacol Exp Ther. 2010; 332(2):505-14.

Couturier JMorel M, Pontcharraud R, Gontier V, Fauconneau BPaccalin MPage G. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid-beta (Abeta)-treated cells and in APPSLPS1 knock-in mice. J Biol Chem. 2010; 285(2):1272-82.

Couturier JPage GMorel M, Gontier C, Lecron JC, Pontcharraud R, Fauconneau BPaccalin M. The inhibition of the double-stranded RNA-dependent protein kinase strongly decreases cytokine production and release in peripheral blood mononuclear cells from Alzheimer patients. JAD. 2010; 21(4):1217-31.

Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S. Time course of MPTP toxicity on translational control protein expression in mice brain. Toxicol Lett. 2010; 196(1):51-5.

Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S. Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice. Neurotox Res. 2010; 17(2):142-55

Wan J, Fu A, Ip F, Ng H-K, Hugon J, Page G, Wang J, Lai K-O, Wu Z, Ip N. Tyk2/STAT3 signaling mediates Aβ-induced neuronal cell death : Implications in Alzheimer’s disease. J Neurosci. 2010; 30(20) :6873-81.

Autres publications

Coudroy R, Debouverie O, Poupet JY, Roblot P, Paccalin M Images in gerontology: a case report. Gerontology. 2010; 56:39-40.

Debouverie O, Coudroy R, Merlet-Chicoine I, Salmon F, Gil R, Paccalin M. Accuracy of fluoropropyl-2beta-carbomethoxy-3beta-(4- iodophenyl) nortropane datscan for the diagnosis of lewy body dementia. J Am Geriatr Soc. 2010; 58:209-10.

Deschamps C, Morel M, Janet TPage G, Jaber M, Gaillard A, Prestoz L. EphrinA5 protein distribution in the developing mouse brain. BMC Neurosci. 2010;11:105.

Kemoun G, Thibaud M, Roumagne N, Carette P, Albinet C, Toussaint L, Paccalin M, Dugué B. Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dement Geriatr Cogn Disord. 2010; 29:109-14.